Authors' reply

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7068.1330c (Published 23 November 1996) Cite this as: BMJ 1996;313:1330
  1. Peter Stubbs,
  2. Mark Noble,
  3. Paul Collinson,
  4. David Moseley,
  5. Trevor Greenwood
  1. Lecturer in cardiovascular medicine Weston professor of cardiovascular medicine Charing Cross and Westminster Medical School, London W6 8RP
  2. Consultant chemical pathologist Mayday University Hospital NHS Trust, Croydon CR4 7YE
  3. Senior medical laboratory scientific officer Consultant cardiologist West Middlesex University NHS Trust, Isleworth TW7 6AF

    EDITOR,—A S Wierzbicki and T M Reynolds's view on thrombolysis is at odds with currently accepted guidelines about which patients benefit from thrombolysis. Confirmation of the potential benefit or otherwise of thrombolysis, revascularisation, and other, newer, therapeutic regimens on patients with an acute coronary syndrome and without ST segment elevation who are positive for troponin T awaits the results of prospective studies. R Lee Kennedy asks whether measurement of troponin T really adds to …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription